secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001213900-23-084013
Event type: regulatory
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne responds to FDA questions on OneRF Ablation System 510(k); expects feedback in 30 days
--------------------------------------------------------------------------------

- Company responded to FDA questions on its 510(k) submission for the OneRF Ablation System.
- FDA feedback expected within 30 days; commercialization targeted for H1 2024 pending clearance.
- OneRF would be first sEEG-guided RF ablation system with real-time temperature control.
- NeuroOne estimates worldwide brain ablation market at $100M+ with rapid growth potential.
- CEO Dave Rosa cites potential to reduce hospital stays, procedures, and complications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023084013/0001213900-23-084013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390023084013/ea187820-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-084013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer